| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX)
CPRX Technical Analysis
4
| As on 9th Jun 2023 CPRX SHARE Price closed @ 11.62 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.52 & Strong Buy for SHORT-TERM with Stoploss of 6.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CPRXSHARE Price
| Open | 11.88 | Change | Price | % |
| High | 11.91 | 1 Day | -0.24 | -2.02 |
| Low | 11.58 | 1 Week | 0.12 | 1.04 |
| Close | 11.62 | 1 Month | -4.47 | -27.78 |
| Volume | 1028982 | 1 Year | 4.72 | 68.41 |
| 52 Week High 21.05 | 52 Week Low 5.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CPRX Daily Charts |
CPRX Intraday Charts |
Whats New @ Bazaartrend |
CPRX Free Analysis |
|
|
CPRX Important Levels Intraday
| RESISTANCE | 12.26 |
| RESISTANCE | 12.05 |
| RESISTANCE | 11.93 |
| RESISTANCE | 11.80 |
| SUPPORT | 11.44 |
| SUPPORT | 11.31 |
| SUPPORT | 11.19 |
| SUPPORT | 10.98 |
CPRX Forecast April 2024
| 4th UP Forecast | 16.96 |
| 3rd UP Forecast | 15.25 |
| 2nd UP Forecast | 14.19 |
| 1st UP Forecast | 13.13 |
| 1st DOWN Forecast | 10.11 |
| 2nd DOWN Forecast | 9.05 |
| 3rd DOWN Forecast | 7.99 |
| 4th DOWN Forecast | 6.28 |
CPRX Weekly Forecast
| 4th UP Forecast | 12.78 |
| 3rd UP Forecast | 12.41 |
| 2nd UP Forecast | 12.18 |
| 1st UP Forecast | 11.95 |
| 1st DOWN Forecast | 11.29 |
| 2nd DOWN Forecast | 11.06 |
| 3rd DOWN Forecast | 10.83 |
| 4th DOWN Forecast | 10.46 |
CPRX Forecast2024
| 4th UP Forecast | 44.13 |
| 3rd UP Forecast | 33.7 |
| 2nd UP Forecast | 27.26 |
| 1st UP Forecast | 20.81 |
| 1st DOWN Forecast | 2.43 |
| 2nd DOWN Forecast | -4.02 |
| 3rd DOWN Forecast | -10.46 |
| 4th DOWN Forecast | -20.89 |
Catalyst Pharmaceuticals Inc ( NASDAQ USA Symbol : CPRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CPRX Business Profile
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS) and myasthenia gravis; and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. Address: 355 Alhambra Circle, Coral Gables, FL, United States, 33134
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service